The England-based automotive technology company said it disclosed the improper payments to the SEC and Justice Department.
By Lewis Ho, Kareena Teh,and Monique Lee
Recent disputes and controversies involving Chinese subsidiaries of foreign pharmaceutical companies have sounded warning bells on legal and ethical issues regarding participation in China’s rapidly growing and evolving pharmaceutical market. This OnPoint explores various scenarios and provides some insight for preemptive measures that can be taken in China.
While pharmaceutical [...]
Including legal fees related to its Foreign Corrupt Practices Act investigation, the global retailer has spent a whopping $438 million in the two years since the New York Times exposed an alleged cover up of bribery in Mexico.
Qualcomm was first informed of related government investigations in 2010.
The U.S. is seeking to compel a holding company with ties to Chinese mega-construction firm Sany Group to sell a wind farm near sensitive military sites in Oregon.
The Georgia-based company contests the allegations but agreed to make compliance changes.
The pharmaceutical company is also under investigation by Chinese authorities over alleged corruption.
By Charles E. Duross, Timothy W. Blakely, James E. Hough, and Daniel P. Levison
Recent anti-corruption enforcement developments in Asia should serve as a call to action for international and domestic companies operating in the region. In light of these developments — which include increased enforcement (and pressure to enforce) anti-corruption laws and an increasing amount [...]
Ralls is appealing the dismissal of its presidential power and CFIUS challenge. The government has brought a lawsuit to force the divestiture of the company’s wind farm purchase.
U.S. authorities and others are looking into the bank’s hiring practices in Asia for possible corruption problems.
By Ling Zhang
Stricter Blacklist Regime
On December 25, 2013, the National Health and Family Planning Commission of China (“National Health Commission”, former Ministry of Health) issued the amended Provisions Regarding the Establishment of Commercial Bribery Blacklist in the Pharmaceutical Purchase and Sales Industries (“Blacklist Provisions”), which came into effect on March 1, 2014.
According to the Blacklist Provisions, [...]
JPMorgan Chase was the first bank to disclose a U.S. government investigation into its hiring practices in China that could violate anti-corruption laws.
The bank’s hiring practices in Asia have drawn U.S. government scrutiny for possible FCPA violations.
The New Jersey-based power company voluntarily disclosed to the DOJ in March 2012 it was examining possible improper gifts and hospitality in China.
Oral arguments have been scheduled for May in the Ralls Corp. appeal of its partially dismissed lawsuit challenging the Committee on Foreign Investment in the United States.